NO20005547L - Myelin base protein peptides and uses thereof - Google Patents
Myelin base protein peptides and uses thereofInfo
- Publication number
- NO20005547L NO20005547L NO20005547A NO20005547A NO20005547L NO 20005547 L NO20005547 L NO 20005547L NO 20005547 A NO20005547 A NO 20005547A NO 20005547 A NO20005547 A NO 20005547A NO 20005547 L NO20005547 L NO 20005547L
- Authority
- NO
- Norway
- Prior art keywords
- protein peptides
- base protein
- myelin base
- myelin
- peptides
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4713—Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurology (AREA)
- Rehabilitation Therapy (AREA)
- Gastroenterology & Hepatology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Hospice & Palliative Care (AREA)
- Rheumatology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Psychiatry (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US7310998A | 1998-05-05 | 1998-05-05 | |
PCT/US1999/009930 WO1999057241A2 (en) | 1998-05-05 | 1999-05-05 | Myelin basic protein peptides and uses thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20005547D0 NO20005547D0 (en) | 2000-11-03 |
NO20005547L true NO20005547L (en) | 2001-01-02 |
Family
ID=22111789
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20005547A NO20005547L (en) | 1998-05-05 | 2000-11-03 | Myelin base protein peptides and uses thereof |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP1080185A4 (en) |
JP (1) | JP2002513558A (en) |
CN (1) | CN1308671A (en) |
AU (1) | AU3789099A (en) |
CA (1) | CA2330826A1 (en) |
HK (1) | HK1039636A1 (en) |
NO (1) | NO20005547L (en) |
NZ (1) | NZ507901A (en) |
WO (1) | WO1999057241A2 (en) |
ZA (1) | ZA200006268B (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2444911A1 (en) * | 2001-05-01 | 2002-11-07 | Andrew Saxon | Fusion molecules and methods for treatment of immune diseases |
US7265208B2 (en) | 2001-05-01 | 2007-09-04 | The Regents Of The University Of California | Fusion molecules and treatment of IgE-mediated allergic diseases |
ITFI20010114A1 (en) | 2001-06-22 | 2002-12-22 | Univ Firenze | GLYCOPEPTIDES, THEIR PREPARATION AND THEIR USE IN THE DIAGNOSIS OR THERAPEUTIC TREATMENT OF MULTIPLE SCLEROSIS |
DK2227486T3 (en) * | 2007-11-20 | 2017-06-19 | Vianex S A | Peptide Analogs and Conjugates Thereby |
KR20200020966A (en) * | 2015-03-30 | 2020-02-26 | 고꾸리쯔 다이가꾸 호우징 오사까 다이가꾸 | Immunizing peptide, method for producing immunizing peptide, pharmaceutical composition for immune disorders containing same, and method for treating immune disorders |
WO2020257221A1 (en) * | 2019-06-18 | 2020-12-24 | The Scripps Research Institute | Methods and compositions for treating inflammatory conditions |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5734023A (en) * | 1991-11-19 | 1998-03-31 | Anergen Inc. | MHC class II β chain/peptide complexes useful in ameliorating deleterious immune responses |
IL115766A0 (en) * | 1994-10-25 | 1996-01-19 | Immulogic Pharma Corp | Composition and treatment for multiple sclerosis |
CA2224205A1 (en) * | 1995-06-07 | 1996-12-19 | Zymogenetics, Inc. | Fused soluble mhc heterodimer-peptide complexes and their uses |
-
1999
- 1999-05-05 AU AU37890/99A patent/AU3789099A/en not_active Abandoned
- 1999-05-05 WO PCT/US1999/009930 patent/WO1999057241A2/en not_active Application Discontinuation
- 1999-05-05 JP JP2000547197A patent/JP2002513558A/en active Pending
- 1999-05-05 CA CA002330826A patent/CA2330826A1/en not_active Abandoned
- 1999-05-05 CN CN99808248A patent/CN1308671A/en active Pending
- 1999-05-05 NZ NZ507901A patent/NZ507901A/en unknown
- 1999-05-05 EP EP99920379A patent/EP1080185A4/en not_active Withdrawn
-
2000
- 2000-11-02 ZA ZA200006268A patent/ZA200006268B/en unknown
- 2000-11-03 NO NO20005547A patent/NO20005547L/en not_active Application Discontinuation
-
2002
- 2002-02-15 HK HK02101092.3A patent/HK1039636A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
ZA200006268B (en) | 2001-08-22 |
CA2330826A1 (en) | 1999-11-11 |
JP2002513558A (en) | 2002-05-14 |
EP1080185A4 (en) | 2005-01-26 |
WO1999057241A2 (en) | 1999-11-11 |
AU3789099A (en) | 1999-11-23 |
WO1999057241A3 (en) | 2000-01-13 |
WO1999057241A9 (en) | 2000-02-17 |
EP1080185A2 (en) | 2001-03-07 |
NO20005547D0 (en) | 2000-11-03 |
NZ507901A (en) | 2003-06-30 |
HK1039636A1 (en) | 2002-05-03 |
CN1308671A (en) | 2001-08-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20000700D0 (en) | Interleukin-18 proteins and their preparation and use | |
NO20040246L (en) | TACIs and BR3 polypeptides and uses thereof | |
EP1461605A4 (en) | Protein and peptide nanoarrays | |
ITMI982280A0 (en) | SOME N-(2-APRIL-PROPIONIL)-SULFONAMIDES AND PHARMACEUTICAL PREPARATIONS WHICH CONTAIN THEM | |
NO982097D0 (en) | peptides | |
NO982098L (en) | peptides | |
IS4496A (en) | Peptide and protein aerosols | |
NO20002320D0 (en) | The dipeptide nitriles | |
NO20034962D0 (en) | Beta-amyloid peptide-binding proteins and polynucleotides encoding the same | |
DE69822917D1 (en) | Sample and hold circuit | |
NO20040880L (en) | Casein-derived peptides and applications thereof in therapy. | |
DE69705017D1 (en) | Drug binding protein | |
NO20005547L (en) | Myelin base protein peptides and uses thereof | |
NO995062D0 (en) | <Beta> -anyloid peptide binding proteins and polynuldeotides encoded for the same | |
GB9918155D0 (en) | Proteins and peptides | |
DE69816241D1 (en) | ACTIVATED PEPTIDES AND CONJUGATES | |
ATA1972000A (en) | RECOMBINANTLY MADE INTESTINAL NPT2B POLYPEPTIDE | |
IL153740A0 (en) | Grf2-binding proteins and applications thereof | |
GB0102447D0 (en) | Protein variants and uses thereof | |
NO20002832D0 (en) | Human thyroid protein ZSig45 and DNA encoding this | |
DK0907370T3 (en) | HLA-A2.1 Binding Peptides and Their Uses | |
NO20006091D0 (en) | Human protein C polypeptide | |
ID26084A (en) | AMINO ANTRASICLINON HERITIES | |
IS8568A (en) | Hydrophobic transformed protein combinations and methods | |
SE9802441D0 (en) | New peptides and use thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |